v3.26.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   737,626,004      
Beginning balance at Dec. 31, 2024 $ 388,748 $ 7,376 $ 1,598,230 $ (2,285) $ (1,214,573)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under stock purchase plans and exercise of stock options and warrants (in shares) [1]   3,983,386      
Issuance of common stock under stock purchase plans and exercise of stock options and warrants [1] 7,677 $ 40 7,637    
Stock-based compensation 11,096   11,096    
Net other comprehensive loss (278)     (278)  
Net loss (62,913)       (62,913)
Ending balance (in shares) at Mar. 31, 2025   741,609,390      
Ending balance at Mar. 31, 2025 344,330 $ 7,416 1,616,963 (2,563) (1,277,486)
Beginning balance (in shares) at Dec. 31, 2024   737,626,004      
Beginning balance at Dec. 31, 2024 388,748 $ 7,376 1,598,230 (2,285) (1,214,573)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (628,621)        
Ending balance (in shares) at Jun. 30, 2025   742,806,672      
Ending balance at Jun. 30, 2025 259,439 $ 7,428 2,097,957 (2,752) (1,843,194)
Beginning balance (in shares) at Mar. 31, 2025   741,609,390      
Beginning balance at Mar. 31, 2025 344,330 $ 7,416 1,616,963 (2,563) (1,277,486)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under stock purchase plans and exercise of stock options and warrants (in shares) [1]   1,197,282      
Issuance of common stock under stock purchase plans and exercise of stock options and warrants [1] 2,222 $ 12 2,210    
Stock-based compensation 478,784   478,784    
Net other comprehensive loss (189)     (189)  
Net loss (565,708)       (565,708)
Ending balance (in shares) at Jun. 30, 2025   742,806,672      
Ending balance at Jun. 30, 2025 $ 259,439 $ 7,428 2,097,957 (2,752) (1,843,194)
Beginning balance (in shares) at Dec. 31, 2025 775,371,200 775,371,200      
Beginning balance at Dec. 31, 2025 $ 658,860 $ 7,754 2,947,805 (2,540) (2,294,159)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under stock purchase plans and exercise of stock options and warrants (in shares)   646,274      
Issuance of common stock under stock purchase plans and exercise of stock options and warrants 3,797 $ 6 3,791    
Stock-based compensation 72,791   72,791    
Net other comprehensive loss (92)     (92)  
Net loss (189,424)       (189,424)
Ending balance (in shares) at Mar. 31, 2026   776,017,474      
Ending balance at Mar. 31, 2026 $ 545,932 $ 7,760 3,024,387 (2,632) (2,483,583)
Beginning balance (in shares) at Dec. 31, 2025 775,371,200 775,371,200      
Beginning balance at Dec. 31, 2025 $ 658,860 $ 7,754 2,947,805 (2,540) (2,294,159)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss $ (405,124)        
Ending balance (in shares) at Jun. 30, 2026 793,120,362 793,120,362      
Ending balance at Jun. 30, 2026 $ 629,983 $ 7,931 3,324,000 (2,665) (2,699,283)
Beginning balance (in shares) at Mar. 31, 2026   776,017,474      
Beginning balance at Mar. 31, 2026 545,932 $ 7,760 3,024,387 (2,632) (2,483,583)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   670,453      
Issuance of common stock upon exercise of stock options 3,665 $ 7 3,658    
Proceeds from at-the-market offering, net of commissions (in shares) [1]   16,432,435      
Proceeds from at-the-market offering, net of commissions [1] 227,413 $ 164 227,249    
Stock-based compensation 68,706   68,706    
Net other comprehensive loss (33)     (33)  
Net loss $ (215,700)       (215,700)
Ending balance (in shares) at Jun. 30, 2026 793,120,362 793,120,362      
Ending balance at Jun. 30, 2026 $ 629,983 $ 7,931 $ 3,324,000 $ (2,665) $ (2,699,283)
[1] Refer to Note 11 – Related Party Transactions